Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Insomnia: chasing the dream.

× No keyword cloud information.

11 in total

Review 1. Histamine H3 receptors and sleep-wake regulation.

Authors: Jian-Sheng Lin; Olga A Sergeeva; Helmut L Haas
Journal: J Pharmacol Exp Ther Date: 2010-09-23 Impact factor: 4.030

Review 2. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.

Authors: S J Wilson; D J Nutt; C Alford; S V Argyropoulos; D S Baldwin; A N Bateson; T C Britton; C Crowe; D-J Dijk; C A Espie; P Gringras; G Hajak; C Idzikowski; A D Krystal; J R Nash; H Selsick; A L Sharpley; A G Wade
Journal: J Psychopharmacol Date: 2010-09-02 Impact factor: 4.153

Review 3. Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes.

Authors: Uwe Rudolph; Frédéric Knoflach
Journal: Nat Rev Drug Discov Date: 2011-07-29 Impact factor: 84.694

4. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application.

Authors: Colin A Espie; Simon D Kyle; Chris Williams; Jason C Ong; Neil J Douglas; Peter Hames; June S L Brown
Journal: Sleep Date: 2012-06-01 Impact factor: 5.849

5. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial.

Authors: Charles M Morin; Annie Vallières; Bernard Guay; Hans Ivers; Josée Savard; Chantal Mérette; Célyne Bastien; Lucie Baillargeon
Journal: JAMA Date: 2009-05-20 Impact factor: 56.272

Review 6. The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies.

Authors: Dieter Riemann; Michael L Perlis
Journal: Sleep Med Rev Date: 2009-02-07 Impact factor: 11.609

7. Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognition.

Authors: Jason M Uslaner; Spencer J Tye; Donnie M Eddins; Xiaohai Wang; Steven V Fox; Alan T Savitz; Jacquelyn Binns; Christopher E Cannon; Susan L Garson; Lihang Yao; Robert Hodgson; Joanne Stevens; Mark R Bowlby; Pamela L Tannenbaum; Joseph Brunner; Terrence P Mcdonald; Anthony L Gotter; Scott D Kuduk; Paul J Coleman; Christopher J Winrow; John J Renger
Journal: Sci Transl Med Date: 2013-04-03 Impact factor: 17.956

3. Identification of the putative binding pocket of valerenic acid on GABAA receptors using docking studies and site-directed mutagenesis.

Authors: D Luger; G Poli; M Wieder; M Stadler; S Ke; M Ernst; A Hohaus; T Linder; T Seidel; T Langer; S Khom; S Hering
Journal: Br J Pharmacol Date: 2015-10-25 Impact factor: 9.473

3 in total

Insomnia: chasing the dream.

Review 1. Histamine H3 receptors and sleep-wake regulation.

Review 2. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.

Review 3. Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes.

4. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application.

5. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial.

Review 6. The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies.

7. Orexin receptor antagonists differ from standard sleep drugs by promoting sleep at doses that do not disrupt cognition.

8. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs.

9. Hypnotics' association with mortality or cancer: a matched cohort study.

10. The history of barbiturates a century after their clinical introduction.

1. Insomnia and hypertension: A misty landscape.

2. A neuron-glia interaction involving GABA transaminase contributes to sleep loss in sleepless mutants.

3. Identification of the putative binding pocket of valerenic acid on GABAA receptors using docking studies and site-directed mutagenesis.